Neuroimaging categorizes four depression subtypes

December 6, 2016 by George Lowery, Cornell University
Credit: CC0 Public Domain

Patients with depression can be categorized into four unique subtypes defined by distinct patterns of abnormal connectivity in the brain, according to new research from Weill Cornell Medicine.

In a collaborative study published Dec. 5 in Nature Medicine, Dr. Conor Liston, an assistant professor of neuroscience in the Feil Family Brain and Mind Institute and an assistant professor of psychiatry at Weill Cornell Medicine, has identified biomarkers in depression by analyzing more than 1,100 functional (fMRI) scans of patients with and of healthy controls, gathered from across the country.

These biomarkers may help doctors to better diagnose depression subtypes and determine which patients would most likely benefit from a targeted neuro-stimulation therapy called , which uses magnetic fields to create electrical impulses in the brain.

"The four subtypes of depression that we discovered vary in terms of their clinical symptoms but, more importantly, they differ in their responses to treatment," Liston said. "We can now predict with high accuracy whether or not a patient will respond to transcranial magnetic stimulation therapy, which is significant because it takes five weeks to know if this type of treatment works."

Approximately 10 percent of Americans are diagnosed with clinical depression each year. It is, by some estimates, the leading cause of disability in many developed countries.

Historically, efforts to characterize depression involved looking at groups of symptoms that tend to co-occur, then testing neurophysiological links. And while past pioneering studies have defined different forms of depression, the association between the various types and the underlying biology has been inconsistent. Further, diagnostic biomarkers have yet to prove useful in distinguishing depressed patients from healthy controls or in reliably predicting treatment response among individuals.

"Depression is typically diagnosed based on things that we are experiencing, but as in election polling, the results you get depend a lot on the way you ask the question," Liston said. "Brain scans are objective."

Researchers from Weill Cornell Medicine and seven other institutions derived the biomarkers by assigning statistical weights to abnormal connections in the brain, then predicting the probability that they belonged to one subtype versus another. The study found that distinct patterns of abnormal functional connectivity in the brain differentiated the four biotypes and were linked with specific symptoms. For example, reduced connectivity in the part of the brain that regulates fear-related behavior and reappraisal of negative emotional stimuli was most severe in biotypes one and four, which exhibited increased anxiety.

Liston will seek to replicate and confirm the results of this research and discover if it is broadly applicable to studying the biology of depression and other forms of mental illness.

"Subtyping is a major problem in psychiatry," Liston said. "It's not just an issue for , and it would be really valuable to have objective biological tests that can help diagnose subtypes of other mental illnesses, such as psychotic disorders, autism and substance abuse syndromes."

Explore further: Selectively rewiring the brain's circuitry to treat depression

More information: Andrew T Drysdale et al. Resting-state connectivity biomarkers define neurophysiological subtypes of depression, Nature Medicine (2016). DOI: 10.1038/nm.4246

Related Stories

Selectively rewiring the brain's circuitry to treat depression

September 30, 2014
On Star Trek, it is easy to take for granted the incredible ability of futuristic doctors to wave small devices over the heads of both humans and aliens, diagnose their problems through evaluating changes in brain activity ...

Scientists show how magnetic pulses change the brain in treatment for depressed patients

August 29, 2015
A group of UK scientists have found a way of understanding how transcranial magnetic stimulation (TMS) can give relief to severely depressed patients. TMS is used as an alternative to Electro-Convulsive Therapy (ECT), but ...

Brain inflammation linked to depression in multiple sclerosis

July 7, 2016
Patients with multiple sclerosis have higher rates of depression than the general population, including people with other life-long disabling diseases. Symptoms of multiple sclerosis arise from an abnormal response of the ...

Study shows direct manipulation of brain can reverse effects of depression

July 22, 2016
Manipulating the brain has been a tool used in the treatment of mental illness for centuries, and treatments have often been controversial. From psychosurgery, including lobotomy and leucotomy, to electro-convulsive therapy, ...

Disruption in brain signals sheds new light on melancholic depression

February 19, 2015
UNSW researchers have identified a distinctive brain signature in people with melancholic depression, supporting calls for its classification as a unique mood disorder type.

Emotion-processing networks disrupted in sufferers of depression

January 20, 2016
Regions of the brain that normally work together to process emotion become decoupled in people who experience multiple episodes of depression, neuroscientists report. The findings may help identify which patients will benefit ...

Recommended for you

What prevents remyelination? New stem cell research reveals a critical culprit

December 18, 2018
New research on remyelination, the spontaneous regeneration of the brain's fatty insulator that keeps neurons communicating, could lead to a novel approach to developing treatments for multiple sclerosis (MS) and other inflammatory ...

Genetic changes tied to rare brain bleeds in babies

December 18, 2018
(HealthDay)—Researchers say they've identified genetic mutations linked with a blood vessel defect that can lead to deadly brain bleeds in babies.

Gene variant found in brain complicit in MS onset

December 18, 2018
Multiple sclerosis (MS) is an autoimmune disease affecting the function of the central nervous system. Up to now, most of the 230 genetic variants associated with the disease have been linked to changes in immune cells. However, ...

Biologists identify promising drug for ALS treatment

December 18, 2018
A drug typically used to treat hepatitis could slow the progression of ALS, also known as Lou Gehrig's disease, according to new research by University of Alberta scientists.

Communication between neural networks

December 18, 2018
The brain is organized into a super-network of specialized networks of nerve cells. For such a brain architecture to function, these specialized networks – each located in a different brain area – need to be able to communicate ...

Neurons with good housekeeping are protected from Alzheimer's

December 17, 2018
Some neurons in the brain protect themselves from Alzheimer's with a cellular cleaning system that sweeps away toxic proteins associated with the disease, according to a new study from Columbia University and the University ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.